NeuroMetrix, Inc. (NURO)
USD 4.47
(1.08%)
USD 4.47
(1.08%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.33 Million USD | 1.46% |
| 2022 | 1.31 Million USD | -21.43% |
| 2021 | 1.67 Million USD | -39.11% |
| 2020 | 2.74 Million USD | -37.05% |
| 2019 | 4.36 Million USD | -27.46% |
| 2018 | 6.01 Million USD | 31.29% |
| 2017 | 4.58 Million USD | 37.88% |
| 2016 | 3.32 Million USD | -4.28% |
| 2015 | 3.47 Million USD | -56.68% |
| 2014 | 8.01 Million USD | 122.53% |
| 2013 | 3.6 Million USD | 73.41% |
| 2012 | 2.07 Million USD | -33.69% |
| 2011 | 3.13 Million USD | 9.23% |
| 2010 | 2.86 Million USD | -40.96% |
| 2009 | 4.85 Million USD | -43.17% |
| 2008 | 8.54 Million USD | -11.39% |
| 2007 | 9.64 Million USD | -21.57% |
| 2006 | 12.29 Million USD | 84.96% |
| 2005 | 6.64 Million USD | 70.65% |
| 2004 | 3.89 Million USD | -92.61% |
| 2003 | 52.72 Million USD | 12.21% |
| 2002 | 46.98 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.61 Million USD | -15.21% |
| 2024 Q3 | 1.2 Million USD | -25.22% |
| 2024 Q1 | 1.9 Million USD | 43.13% |
| 2023 Q1 | 1.59 Million USD | 21.57% |
| 2023 FY | 1.33 Million USD | 1.46% |
| 2023 Q4 | 1.33 Million USD | -3.62% |
| 2023 Q3 | 1.38 Million USD | 1.55% |
| 2023 Q2 | 1.36 Million USD | -14.73% |
| 2022 FY | 1.31 Million USD | -21.43% |
| 2022 Q1 | 2.01 Million USD | 20.21% |
| 2022 Q2 | 1.84 Million USD | -8.16% |
| 2022 Q3 | 2.06 Million USD | 11.9% |
| 2022 Q4 | 1.31 Million USD | -36.41% |
| 2021 FY | 1.67 Million USD | -39.11% |
| 2021 Q4 | 1.67 Million USD | -19.04% |
| 2021 Q1 | 2.45 Million USD | -10.45% |
| 2021 Q2 | 1.93 Million USD | -21.39% |
| 2021 Q3 | 2.06 Million USD | 6.82% |
| 2020 Q2 | 3.11 Million USD | -15.59% |
| 2020 Q1 | 3.69 Million USD | -15.38% |
| 2020 Q3 | 2.96 Million USD | -4.77% |
| 2020 Q4 | 2.74 Million USD | -7.46% |
| 2020 FY | 2.74 Million USD | -37.05% |
| 2019 Q4 | 4.36 Million USD | -11.55% |
| 2019 Q2 | 5.95 Million USD | 4.24% |
| 2019 Q1 | 5.71 Million USD | -5.01% |
| 2019 FY | 4.36 Million USD | -27.46% |
| 2019 Q3 | 4.93 Million USD | -17.18% |
| 2018 FY | 6.01 Million USD | 31.29% |
| 2018 Q2 | 4.08 Million USD | 17.22% |
| 2018 Q1 | 3.48 Million USD | -23.91% |
| 2018 Q4 | 6.01 Million USD | 43.96% |
| 2018 Q3 | 4.17 Million USD | 2.25% |
| 2017 FY | 4.58 Million USD | 37.88% |
| 2017 Q4 | 4.58 Million USD | 7.68% |
| 2017 Q3 | 4.25 Million USD | 14.67% |
| 2017 Q2 | 3.71 Million USD | 14.63% |
| 2017 Q1 | 3.23 Million USD | -2.59% |
| 2016 Q4 | 3.32 Million USD | -8.69% |
| 2016 Q1 | 3.45 Million USD | -0.46% |
| 2016 Q2 | 3.01 Million USD | -12.77% |
| 2016 FY | 3.32 Million USD | -4.28% |
| 2016 Q3 | 3.63 Million USD | 20.72% |
| 2015 Q2 | 4.41 Million USD | -40.76% |
| 2015 FY | 3.47 Million USD | -56.68% |
| 2015 Q4 | 3.47 Million USD | -21.78% |
| 2015 Q3 | 4.43 Million USD | 0.58% |
| 2015 Q1 | 7.44 Million USD | -7.06% |
| 2014 Q2 | 7.75 Million USD | 127.4% |
| 2014 Q4 | 8.01 Million USD | 8.79% |
| 2014 FY | 8.01 Million USD | 122.53% |
| 2014 Q1 | 3.4 Million USD | -5.36% |
| 2014 Q3 | 7.36 Million USD | -4.95% |
| 2013 Q2 | 5 Million USD | 150.94% |
| 2013 Q3 | 3.89 Million USD | -22.21% |
| 2013 Q4 | 3.6 Million USD | -7.55% |
| 2013 FY | 3.6 Million USD | 73.41% |
| 2013 Q1 | 1.99 Million USD | -3.91% |
| 2012 Q2 | 2.57 Million USD | 4.53% |
| 2012 Q3 | 2.61 Million USD | 1.59% |
| 2012 Q4 | 2.07 Million USD | -20.52% |
| 2012 Q1 | 2.46 Million USD | -21.43% |
| 2012 FY | 2.07 Million USD | -33.69% |
| 2011 FY | 3.13 Million USD | 9.23% |
| 2011 Q1 | 2.64 Million USD | -7.63% |
| 2011 Q4 | 3.13 Million USD | 3.43% |
| 2011 Q3 | 3.02 Million USD | 29.36% |
| 2011 Q2 | 2.34 Million USD | -11.62% |
| 2010 FY | 2.86 Million USD | -40.96% |
| 2010 Q3 | 3.9 Million USD | -4.32% |
| 2010 Q4 | 2.86 Million USD | -26.57% |
| 2010 Q2 | 4.08 Million USD | -10.74% |
| 2010 Q1 | 4.57 Million USD | -5.85% |
| 2009 Q1 | 5.15 Million USD | -39.71% |
| 2009 FY | 4.85 Million USD | -43.17% |
| 2009 Q4 | 4.85 Million USD | -82.33% |
| 2009 Q3 | 27.48 Million USD | 422.02% |
| 2009 Q2 | 5.26 Million USD | 2.19% |
| 2008 Q2 | 7.82 Million USD | -16.88% |
| 2008 Q1 | 9.41 Million USD | -2.38% |
| 2008 Q4 | 8.54 Million USD | 12.88% |
| 2008 Q3 | 7.57 Million USD | -3.27% |
| 2008 FY | 8.54 Million USD | -11.39% |
| 2007 Q3 | 11.07 Million USD | 7.19% |
| 2007 Q1 | 11.52 Million USD | -6.28% |
| 2007 FY | 9.64 Million USD | -21.57% |
| 2007 Q4 | 9.64 Million USD | -12.92% |
| 2007 Q2 | 10.33 Million USD | -10.35% |
| 2006 Q1 | 6.89 Million USD | 3.74% |
| 2006 Q2 | 7.26 Million USD | 5.37% |
| 2006 Q3 | 8.75 Million USD | 20.49% |
| 2006 Q4 | 12.29 Million USD | 40.42% |
| 2006 FY | 12.29 Million USD | 84.96% |
| 2005 Q1 | 4.97 Million USD | 27.74% |
| 2005 FY | 6.64 Million USD | 70.65% |
| 2005 Q4 | 6.64 Million USD | 20.11% |
| 2005 Q3 | 5.53 Million USD | 5.09% |
| 2005 Q2 | 5.26 Million USD | 5.84% |
| 2004 Q2 | 74.13 Million USD | 3.41% |
| 2004 Q3 | 3.27 Million USD | -95.58% |
| 2004 FY | 3.89 Million USD | -92.61% |
| 2004 Q4 | 3.89 Million USD | 18.97% |
| 2004 Q1 | 71.69 Million USD | 35.98% |
| 2003 FY | 52.72 Million USD | 12.21% |
| 2003 Q4 | 52.72 Million USD | 0.0% |
| 2002 FY | 46.98 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 97.399% |
| BrainsWay Ltd. | 15.31 Million USD | 91.295% |
| Cerus Corporation | 144.3 Million USD | 99.076% |
| Envoy Medical, Inc. | 9.4 Million USD | 85.821% |
| electroCore, Inc. | 8.94 Million USD | 85.096% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | 75.044% |
| IceCure Medical Ltd | 4.24 Million USD | 68.61% |
| Inogen, Inc. | 121.38 Million USD | 98.902% |
| OrthoPediatrics Corp. | 72.56 Million USD | 98.163% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 95.493% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | 58.103% |
| MaxCyte, Inc. | 36.1 Million USD | 96.308% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | 27.858% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -213.469% |
| Orthofix Medical Inc. | 326.58 Million USD | 99.592% |
| PAVmed Inc | 57.13 Million USD | 97.667% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 94.764% |
| RxSight, Inc. | 22.18 Million USD | 93.992% |
| Sight Sciences, Inc. | 46.43 Million USD | 97.129% |
| SI-BONE, Inc. | 61.05 Million USD | 97.816% |
| TELA Bio, Inc. | 59.16 Million USD | 97.747% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 98.83% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | 87.081% |
| Acutus Medical, Inc. | 54.83 Million USD | 97.569% |
| Talis Biomedical Corporation | 29.22 Million USD | 95.438% |
| Spectral AI, Inc. | 12.4 Million USD | 89.25% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 94.237% |
| CVRx, Inc. | 39.28 Million USD | 96.606% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | 88.852% |
| PetVivo Holdings, Inc. | 2.42 Million USD | 45.123% |
| Bioventus Inc. | 589.79 Million USD | 99.774% |
| Venus Concept Inc. | 107.1 Million USD | 98.755% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 97.42% |
| LivaNova PLC | 1.15 Billion USD | 99.884% |
| 908 Devices Inc. | 37.49 Million USD | 96.444% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 99.81% |
| Nemaura Medical Inc. | 26.37 Million USD | 94.946% |
| NeuroPace, Inc. | 86.99 Million USD | 98.468% |
| LENSAR, Inc. | 22.4 Million USD | 94.051% |
| Apyx Medical Corporation | 52.31 Million USD | 97.452% |
| Cutera, Inc. | 518.12 Million USD | 99.743% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 95.454% |
| BioSig Technologies, Inc. | 4.68 Million USD | 71.545% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 97.716% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 93.796% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.939% |
| Axonics, Inc. | 82.35 Million USD | 98.381% |
| Outset Medical, Inc. | 190.91 Million USD | 99.302% |
| IRIDEX Corporation | 24.91 Million USD | 94.649% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 98.925% |
| IRadimed Corporation | 20.73 Million USD | 93.571% |
| Tivic Health Systems, Inc. | 1.67 Million USD | 20.363% |
| INVO Bioscience, Inc. | 19.99 Million USD | 93.333% |
| Telesis Bio, Inc. | 40.87 Million USD | 96.738% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 96.732% |
| Varex Imaging Corporation | 668.6 Million USD | 99.801% |
| Quipt Home Medical Corp. | 136.29 Million USD | 99.022% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 62.678% |
| Pulmonx Corporation | 60.63 Million USD | 97.801% |
| Dynatronics Corporation | 11.78 Million USD | 88.683% |
| Modular Medical, Inc. | 2.27 Million USD | 41.324% |
| ReShape Lifesciences Inc. | 4.06 Million USD | 67.197% |
| Semler Scientific, Inc. | 6.27 Million USD | 78.738% |
| InMode Ltd. | 75.91 Million USD | 98.244% |
| Bruker Corporation | 2.83 Billion USD | 99.953% |
| Cytosorbents Corporation | 29.98 Million USD | 95.554% |
| DexCom, Inc. | 4.19 Billion USD | 99.968% |
| Align Technology, Inc. | 2.45 Billion USD | 99.946% |
| Viveve Medical, Inc. | 10.84 Million USD | 87.71% |
| ZimVie Inc. | 795.85 Million USD | 99.832% |
| Movano Inc. | 5.97 Million USD | 77.677% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 98.726% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -213.469% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 88.852% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 99.791% |
| Profound Medical Corp. | 12.66 Million USD | 89.475% |
| Insulet Corporation | 1.85 Billion USD | 99.928% |
| enVVeno Medical Corporation | 2.43 Million USD | 45.252% |
| Surmodics, Inc. | 65.82 Million USD | 97.975% |
| iCAD, Inc. | 8 Million USD | 83.338% |
| Nuwellis, Inc. | 6.78 Million USD | 80.337% |
| Biotricity, Inc. | 35.91 Million USD | 96.289% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 99.402% |
| Aethlon Medical, Inc. | 2.47 Million USD | 46.237% |
| InspireMD, Inc. | 8.14 Million USD | 83.627% |
| PAVmed Inc. | 57.13 Million USD | 97.667% |
| BIOLASE, Inc. | 35.34 Million USD | 96.229% |
| Beyond Air, Inc. | 29.77 Million USD | 95.523% |
| FONAR Corporation | 57.45 Million USD | 97.68% |
| AxoGen, Inc. | 101.16 Million USD | 98.682% |
| Vivani Medical, Inc. | 25.03 Million USD | 94.675% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 98.482% |
| Inari Medical, Inc. | 209.32 Million USD | 99.363% |
| UFP Technologies, Inc. | 118.04 Million USD | 98.871% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | 89.495% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | 39.01% |
| Tenon Medical, Inc. | 5.56 Million USD | 76.053% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | 25.063% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 92.44% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.958% |
| Sintx Technologies, Inc. | 6.59 Million USD | 79.78% |
| NanoVibronix, Inc. | 2.68 Million USD | 50.368% |
| Quanterix Corporation | 78.08 Million USD | 98.293% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 62.678% |
| Sensus Healthcare, Inc. | 4.88 Million USD | 72.71% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 99.872% |
| TransMedics Group, Inc. | 568.84 Million USD | 99.766% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 92.009% |
| Hyperfine, Inc. | 9.8 Million USD | 86.397% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 99.467% |
| Biomerica, Inc. | 2.66 Million USD | 49.939% |
| Bone Biologics Corporation | 831.4 Thousand USD | -60.346% |
| AVITA Medical, Inc. | 19.86 Million USD | 93.289% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | 32.455% |
| Silk Road Medical, Inc | 114.15 Million USD | 98.832% |